Ecuador vs Guinea-Bissau: Proportion of the target population who received a 3rd dose of
Ecuador
71.0%
in 2024
Guinea-Bissau
74.0%
in 2024
Ecuador rank
131st
Guinea-Bissau rank
127th
Proportion of the target population who received a 3rd dose of over time
- Ecuador
- Guinea-Bissau
How they compare
Guinea-Bissau currently reports 74.0% against 71.0% in Ecuador, a difference of 3.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Ecuador ahead.
Ecuador ranks 131st and Guinea-Bissau ranks 127th of 157 countries.
Across the 2 decades both report, Ecuador averaged higher in 1 and Guinea-Bissau in 1.
Head to head by decade
| Decade | Ecuador | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 83.4% | 66.4% | 17.0% | Ecuador |
| 2020s | 70.2% | 72.6% | 2.4% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Ecuador or Guinea-Bissau?
- Guinea-Bissau, at 74.0% against 71.0% in Ecuador as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Ecuador and Guinea-Bissau?
- 3.0%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Ecuador and Guinea-Bissau?
- 10 years are reported by both, from 2015 to 2024.
- How do Ecuador and Guinea-Bissau rank globally for proportion of the target population who received a 3rd dose of?
- Ecuador ranks 131st and Guinea-Bissau ranks 127th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.